Suvorexant metabolite M9 is a compound related to the active metabolite of the drug suvorexant, characterized by a complex structure containing a diazepane ring and multiple aromatic heterocycles. It is primarily of significance as a reference standard or research compound in pharmaceutical development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Suvorexant metabolite M9?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
5-chloro-2-[(5S)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole
pharmaceutical raw material
Suvorexant
pharmaceutical raw material
(R)-(-)-1-Aminoindane hydrochloride
pharmaceutical raw material
(2R)-daptomycin
pharmaceutical raw material
Tribenoside
pharmaceutical raw material
Levamlodipine
pharmaceutical raw material
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-(hydroxymethyl)-2-(triazol-2-yl)phenyl]methanone
GALQAEACISWTMT-OAHLLOKOSA-N
C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)CO)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl
Sourcing Suvorexant metabolite M9?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.